Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fujimoto, M.
Right arrow Articles by Naka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujimoto, M.
Right arrow Articles by Naka, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 16, No. 2, pp. 303-314, February 2004
© 2004 Japanese Society for Immunology

Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases

Minoru Fujimoto1, Hiroko Tsutsui2,5, Ouyang Xinshou1, Masanori Tokumoto3, Dai Watanabe1, Yoshihito Shima1, Tomohiro Yoshimoto2,5, Hideki Hirakata3, Ichiro Kawase1, Kenji Nakanishi2,5, Tadamitsu Kishimoto4 and Tetsuji Naka1

1 Department of Molecular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka 565-0871, Japan 2 Department of Immunology and Medical Zoology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan 3 Department of Medicine and Clinical Science, Graduate School of Medical Science, Kyushu University, Fukuoka 812-8582, Japan 4 Osaka University, Osaka 565-0871, Japan 5 Core Research for Evolutional Science and Technology, Japan Science and Technology Corp., Tokyo 101-0062, Japan

Correspondence to: T. Naka; E-mail: naka{at}imed3.med.osaka-u.ac.jp
Transmitting editor: T. Watanabe

Suppressor of cytokine signaling (SOCS)-1 is a cytokine-inducible, negative regulatory molecule of Janus kinases (JAK) and its deficiency causes hyper-response to various cytokines. SOCS-1–/– mice spontaneously develop a fatal disease depending on aberrantly activated lymphocytes. Here, we show that partial restoration of SOCS-1 in lymphoid cells rescues SOCS-1–/– mice from the early-onset fatal disease, indicating that SOCS-1 expression in vivo is especially required in lymphocytes. However, SOCS-1 expression in these SOCS-1-restored mutant mice (Eµ-SOCS-1–/– mice) was insufficient for proper down-regulation of its target signaling, and these mice spontaneously exhibit hyperactivation of lymphocytes, an increase in the levels of serum Ig and anti-DNA autoantibodies, and glomerulonephritis with glomerular IgG deposition. These phenotypes resemble those of murine systemic autoimmune diseases, models for systemic lupus erythematosus (SLE). Interestingly, similar phenotypes were also observed in adult female SOCS-1+/– mice, indicating that the autoimmune phenotypes of these mice can be ascribed primarily to the inadequate expression of SOCS-1. In addition, autoimmune phenotypes were not observed in SOCS-1+/–CD4–/– mice, suggesting that autoimmunity is dependent on hyper-activated CD4+ T cells. Our findings also suggest that insufficient expression of SOCS-1 results in impaired function of CD25+CD4+ regulatory T cells, which may contribute to aberrant activation of CD4+ T cells. These findings suggest that dysfunction of SOCS-1 can be a pathogenic factor of systemic autoimmune diseases such as SLE.

Keywords: autoantibody, Janus kinase, STAT-induced STAT inhibitor, suppressor of cytokine signaling, systemic lupus erythematosus


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
J. Yates, F. Rovis, P. Mitchell, B. Afzali, J.-S Tsang, M. Garin, R. Lechler, G. Lombardi, and O. Garden
The maintenance of human CD4+CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro
Int. Immunol., June 1, 2007; 19(6): 785 - 799.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
J Dong, Q-X Wang, C-Y Zhou, X-F Ma, and Y-C Zhang
Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice
Lupus, February 1, 2007; 16(2): 101 - 109.
[Abstract] [PDF]


Home page
J. Leukoc. Biol.Home page
N. M. Moutsopoulos, N. Vazquez, T. Greenwell-Wild, I. Ecevit, J. Horn, J. Orenstein, and S. M. Wahl
Regulation of the tonsil cytokine milieu favors HIV susceptibility
J. Leukoc. Biol., November 1, 2006; 80(5): 1145 - 1155.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.